Amneal Pharmaceuticals (AMRX) Short Interest Ratio & Short Volume → Global crypto currency reset (41 major banks signed up) (From Stansberry Research) (Ad) Free AMRX Stock Alerts $6.66 +0.19 (+2.94%) (As of 05/10/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Amneal Pharmaceuticals Short Interest DataCurrent Short Volume2,370,000 sharesPrevious Short Volume2,800,000 sharesChange Vs. Previous Month-15.36%Dollar Volume Sold Short$14.34 millionShort Interest Ratio / Days to Cover1.5Last Record DateApril 30, 2024Outstanding Shares307,010,000 sharesFloat Size102,520,000 sharesShort Percent of Float2.31%Today's Trading Volume1,142,242 sharesAverage Trading Volume1,798,087 sharesToday's Volume Vs. Average64% Short Selling Amneal Pharmaceuticals ? Sign up to receive the latest short interest report for Amneal Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAMRX Short Interest Over TimeAMRX Days to Cover Over TimeAMRX Percentage of Float Shorted Over Time Ad Crypto 101 MediaElon Musk Secret Crypto Plot ExposedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. Amneal Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20242,370,000 shares $14.34 million -15.4%2.3%1.5 $6.05 4/15/20242,800,000 shares $15.51 million +16.7%2.5%1.8 $5.54 3/31/20242,400,000 shares $14.54 million +15.9%2.2%1.6 $6.06 3/15/20242,070,000 shares $11.39 million +13.1%1.9%1.4 $5.50 2/29/20241,830,000 shares $10.10 million -12.9%1.7%1.2 $5.52 2/15/20242,100,000 shares $12.37 million -17.3%1.9%1.5 $5.89 Get the Latest News and Ratings for AMRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amneal Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/20242,540,000 shares $13.59 million +1.6%2.3%1.9 $5.35 12/15/20232,650,000 shares $13.75 million -16.7%2.4%1.9 $5.19 11/30/20233,180,000 shares $13.71 million -12.2%5.8%2.5 $4.31 11/15/20233,620,000 shares $16.25 million +13.5%6.5%2.9 $4.49 10/31/20233,190,000 shares $12.33 million +4.3%3.1%2.6 $3.87 10/15/20233,060,000 shares $11.75 million -20.5%3.0%2.4 $3.84 9/30/20233,850,000 shares $16.25 million +4.3%3.7%3.4 $4.22 9/15/20233,690,000 shares $15.17 million +1.9%3.6%3.4 $4.11 8/31/20233,620,000 shares $14.81 million +3.7%3.5%3.1 $4.09 8/15/20233,490,000 shares $13.66 million -3.6%3.4%3 $3.92 7/31/20233,620,000 shares $11.58 million -12.8%3.6%3.3 $3.20 7/15/20234,150,000 shares $12.57 million +0.2%4.1%4 $3.03 6/30/20234,140,000 shares $12.83 million -4.6%4.1%3.9 $3.10 6/15/20234,340,000 shares $11.72 million -13.6%4.3%4.4 $2.70 5/31/20235,020,000 shares $11.75 million +7.3%4.9%5.3 $2.34 5/15/20234,680,000 shares $9.45 million -24.8%4.6%4.9 $2.02 4/30/20236,220,000 shares $12.00 million -9.9%6.3%6.2 $1.93 4/15/20236,900,000 shares $9.38 million +7.1%6.9%6.3 $1.36 3/31/20236,440,000 shares $8.95 million -13.1%6.5%6.1 $1.39 3/15/20237,410,000 shares $10.08 million +4.1%8.9%6.6 $1.36 2/28/20237,120,000 shares $14.67 million -11.7%7.2%5.5 $2.06 2/15/20238,060,000 shares $20.23 million -11.5%8.1%6.6 $2.51 1/31/20239,110,000 shares $20.04 million +10.6%9.1%7.1 $2.20 1/15/20238,240,000 shares $18.29 million +6.5%8.3%7.1 $2.22 12/30/20227,740,000 shares $15.40 million +142.6%7.8%6.8 $1.99 12/15/20223,190,000 shares $7.24 million -12.6%3.3%2.9 $2.27 11/30/20223,650,000 shares $9.34 million -15.3%3.8%3.5 $2.56 11/15/20224,310,000 shares $9.91 million -7.9%4.5%4.4 $2.30 10/31/20224,680,000 shares $10.30 million -2.9%4.8%4 $2.20 10/15/20224,820,000 shares $9.45 million +2.6%5.0%4.3 $1.96 9/30/20224,700,000 shares $9.49 million +2.2%4.8%4.3 $2.02 9/15/20224,600,000 shares $10.81 million +15.3%4.7%4.3 $2.35 8/31/20223,990,000 shares $8.66 million +7.3%4.1%3.9 $2.17 8/15/20223,720,000 shares $11.87 million +9.4%3.8%4.1 $3.19A.I. is a Tidal Wave - Here’s What to Buy (Ad)The internet generated more wealth than any other innovation in history - creating hundreds of thousands of new millionaires in America alone. Now A.I. could do the same. But if you're buying Microsoft or NVIDIA to profit - you're missing the big picture.Get the name and ticker symbol for free - just click here. AMRX Short Interest - Frequently Asked Questions What is Amneal Pharmaceuticals' current short interest? Short interest is the volume of Amneal Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 2,370,000 shares of AMRX short. 2.31% of Amneal Pharmaceuticals' shares are currently sold short. Learn More on Amneal Pharmaceuticals' current short interest. What is a good short interest ratio for Amneal Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AMRX shares currently have a short interest ratio of 2.0. Learn More on Amneal Pharmaceuticals's short interest ratio. Which institutional investors are shorting Amneal Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Amneal Pharmaceuticals: Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Amneal Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.31% of Amneal Pharmaceuticals' floating shares are currently sold short. Is Amneal Pharmaceuticals' short interest increasing or decreasing? Amneal Pharmaceuticals saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 2,370,000 shares, a drop of 15.4% from the previous total of 2,800,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Amneal Pharmaceuticals' float size? Amneal Pharmaceuticals currently has issued a total of 307,010,000 shares. Some of Amneal Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Amneal Pharmaceuticals currently has a public float of 102,520,000 shares. How does Amneal Pharmaceuticals' short interest compare to its competitors? 2.31% of Amneal Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Amneal Pharmaceuticals: Structure Therapeutics Inc. (10.35%), Syndax Pharmaceuticals, Inc. (11.90%), Agios Pharmaceuticals, Inc. (11.77%), Evotec SE (0.05%), Catalyst Pharmaceuticals, Inc. (7.59%), Galapagos NV (2.41%), NewAmsterdam Pharma (0.96%), Avidity Biosciences, Inc. (11.91%), Supernus Pharmaceuticals, Inc. (9.16%), Rocket Pharmaceuticals, Inc. (10.84%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Amneal Pharmaceuticals stock? Short selling AMRX is an investing strategy that aims to generate trading profit from Amneal Pharmaceuticals as its price is falling. AMRX shares are trading up $0.19 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Amneal Pharmaceuticals? A short squeeze for Amneal Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AMRX, which in turn drives the price of the stock up even further. How often is Amneal Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AMRX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Structure Therapeutics Short Interest Data Syndax Pharmaceuticals Short Interest Data Agios Pharmaceuticals Short Interest Data Evotec Short Interest Data Catalyst Pharmaceuticals Short Interest Data Galapagos Short Interest Data NewAmsterdam Pharma Short Interest Data Avidity Biosciences Short Interest Data Supernus Pharmaceuticals Short Interest Data Rocket Pharmaceuticals Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AMRX) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHow Biden has already won 2024Porter & CompanyRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable ProsperityThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings